The AVICCI study

• Research type

  Research Study

• Full title

  A feasibility study to assess the effects of AntiretroViral Intensification with Cenicriviroc for the management of HIV-associated Cognitive Impairment. The AVICCI study

• IRAS ID

  186989

• Contact name

  Alan Winston

• Contact email

  a.winston@imperial.ac.uk

• Sponsor organisation

  Imperial College London

• Eudract number

  2015-002955-85

• Duration of Study in the UK

  0 years, 4 months, 31 days

• Research summary

  HIV antiretriviral treatment has revolutionised the outlook for persons-living-with-HIV (PLWH) from that of an illness associated with a high morbidity and mortality to a chronic manageable medical condition. But 5-10% of those who are successfully treated develop clinically significant cognative function impairment.
  This study will look at if there is an improvement in cognative function when a new drug is added to the patients current antiretroviral medications

• REC name

  London - Brighton & Sussex Research Ethics Committee

• REC reference

  15/LO/1887

• Date of REC Opinion

  24 Nov 2015

• REC opinion

  Further Information Favourable Opinion